Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan A Erkes

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Immunology Research|June 21, 2014
Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunityDan A Erkes, Senthamil R Selvan
Immunotherapy|January 21, 2016
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vectorMichael Quinn, Dan A Erkes, Christopher M Snyder
Human Vaccines & Immunotherapeutics|June 13, 2017
Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunityDan A Erkes, Nicole A Wilski, Christopher M Snyder
The Journal of Investigative Dermatology|February 1, 2019
BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 BlockadeNeda Nikbakht, Manoela Tiago, Dan A Erkes, et al.
Pigment Cell & Melanoma Research|November 8, 2019
PLX3397 inhibits the accumulation of intra-tumoral macrophages and improves bromodomain and extra-terminal inhibitor efficacy in melanomaDan A Erkes, Sheera R Rosenbaum, Conroy O Field, et al.
Nature Communications|April 13, 2019
Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activationCorey Rogers, Dan A Erkes, Alexandria Nardone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2017
Virus-Specific CD8<sup>+</sup> T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 ExpressionDan A Erkes, Corinne J Smith, Nicole A Wilski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 20, 2016
Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term ImmunityDan A Erkes, Guangwu Xu, Constantine Daskalakis, et al.
British Journal of Cancer|January 15, 2020
Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanomaManoela Tiago, Claudia Capparelli, Dan A Erkes, et al.
Journal of Virology|July 14, 2021
Mechanisms of Antiviral Cytotoxic CD4 T Cell DifferentiationCory J Knudson, Maria Férez, Pedro Alves-Peixoto, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Immunology Research|June 21, 2014
Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunityDan A Erkes, Senthamil R Selvan
Immunotherapy|January 21, 2016
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vectorMichael Quinn, Dan A Erkes, Christopher M Snyder
Human Vaccines & Immunotherapeutics|June 13, 2017
Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunityDan A Erkes, Nicole A Wilski, Christopher M Snyder
The Journal of Investigative Dermatology|February 1, 2019
BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 BlockadeNeda Nikbakht, Manoela Tiago, Dan A Erkes, et al.
Pigment Cell & Melanoma Research|November 8, 2019
PLX3397 inhibits the accumulation of intra-tumoral macrophages and improves bromodomain and extra-terminal inhibitor efficacy in melanomaDan A Erkes, Sheera R Rosenbaum, Conroy O Field, et al.
Nature Communications|April 13, 2019
Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activationCorey Rogers, Dan A Erkes, Alexandria Nardone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2017
Virus-Specific CD8<sup>+</sup> T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 ExpressionDan A Erkes, Corinne J Smith, Nicole A Wilski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 20, 2016
Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term ImmunityDan A Erkes, Guangwu Xu, Constantine Daskalakis, et al.
British Journal of Cancer|January 15, 2020
Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanomaManoela Tiago, Claudia Capparelli, Dan A Erkes, et al.
Journal of Virology|July 14, 2021
Mechanisms of Antiviral Cytotoxic CD4 T Cell DifferentiationCory J Knudson, Maria Férez, Pedro Alves-Peixoto, et al.
Pageof 4